{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T12:23:27Z","timestamp":1755692607342},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropeptides"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.npep.2012.11.001","type":"journal-article","created":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T21:02:42Z","timestamp":1356037362000},"page":"67-73","source":"Crossref","is-referenced-by-count":18,"title":["Systemic treatment with neuropeptide Y receptor Y1-antagonist enhances atherosclerosis and stimulates IL-12 expression in ApoE deficient mice"],"prefix":"10.1016","volume":"47","author":[{"given":"A.E.","family":"J\u00e4\u00e4skel\u00e4inen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Sepp\u00e4l\u00e4","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Kakko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Jaakkola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Kallio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.npep.2012.11.001_b0005","doi-asserted-by":"crossref","first-page":"24715","DOI":"10.1074\/jbc.M109.035253","article-title":"Kinetic study of neuropeptide Y (NPY) proteolysis in blood and identification of NPY3-35: a new peptide generated by plasma kallikrein","volume":"284","author":"Abid","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.npep.2012.11.001_b0010","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1161\/01.ATV.19.6.1518","article-title":"Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice","volume":"19","author":"Aiello","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.npep.2012.11.001_b0015","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1007\/s00125-011-2274-6","article-title":"Altered endocannabinoid signalling after a high-fat diet in Apoe(\u2212\/\u2212) mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance","volume":"54","author":"Bartelt","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.npep.2012.11.001_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-5728(02)00424-1","article-title":"Relevance of neuropeptide Y for the neuroimmune crosstalk","volume":"134","author":"Bedoui","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.npep.2012.11.001_b0025","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/PL00005100","article-title":"The Y1 antagonist BIBP 3226 inhibits potentiation of methoxamine-induced vasoconstriction by neuropeptide Y","volume":"356","author":"Bischoff","year":"1997","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.npep.2012.11.001_b0030","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.atherosclerosis.2005.02.014","article-title":"The potential role of resistin in atherogenesis","volume":"182","author":"Burnett","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.npep.2012.11.001_b0035","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0002-9440(10)63471-2","article-title":"The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice","volume":"163","author":"Davenport","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.npep.2012.11.001_b0040","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.regpep.2004.07.012","article-title":"Neuropeptide Y and its receptor subtypes specifically modulate rat peritoneal macrophage functions in vitro: counter regulation through Y1 and Y2\/5 receptors","volume":"124","author":"Dimitrijevic","year":"2005","journal-title":"Regul. Pept."},{"key":"10.1016\/j.npep.2012.11.001_b0045","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1096\/fj.03-0189fje","article-title":"The neuropeptide Y Y1 receptor mediates NPY-induced inhibition of the gonadotrope axis under poor metabolic conditions","volume":"18","author":"Gonzales","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.npep.2012.11.001_b0050","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/sj.bjp.0706774","article-title":"Neuropeptide Y2 receptors are involved in enhanced neurogenic vasoconstriction in spontaneously hypertensive rats","volume":"148","author":"Gradin","year":"2006","journal-title":"Br. J. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.npep.2012.11.001_b0255","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1538-7836.2009.03416.x","article-title":"Inflammatory mechanisms in atherosclerosis","author":"Hansson","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.npep.2012.11.001_b0060","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/01.RES.0000029784.15893.10","article-title":"Innate and adaptive immunity in the pathogenesis of atherosclerosis","volume":"91","author":"Hansson","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.npep.2012.11.001_b0065","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1161\/CIRCULATIONAHA.104.533463","article-title":"Blockade of interleukin-12 function by protein vaccination attenuates atherosclerosis","volume":"112","author":"Hauer","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.npep.2012.11.001_b0070","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.mvr.2010.07.010","article-title":"The Leu7Pro polymorphism of the signal peptide of neuropeptide Y (NPY) gene is associated with increased levels of inflammatory markers preceding vascular complications in patients with type 2 diabetes","volume":"80","author":"Jaakkola","year":"2010","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.npep.2012.11.001_b0075","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/1479164111415882","article-title":"Inflammatory effects of blood leukocytes: association with vascular function in neuropeptide Y proline 7-genotyped type 2 diabetes patients","volume":"8","author":"Kakko","year":"2011","journal-title":"Diab. Vasc. Dis. Res."},{"key":"10.1016\/j.npep.2012.11.001_b0085","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1210\/jc.2002-021957","article-title":"Changes in diurnal sympathoadrenal balance and pituitary hormone secretion in subjects with Leu7Pro polymorphism in the prepro-neuropeptide Y","volume":"88","author":"Kallio","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.npep.2012.11.001_b0080","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1096\/fj.00-0436fje","article-title":"Altered intracellular processing and release of neuropeptide Y due to leucine 7 to proline 7 polymorphism in the signal peptide of preproneuropeptide Y in humans","volume":"15","author":"Kallio","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.npep.2012.11.001_b0095","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/4027","article-title":"Association of a leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels","volume":"4","author":"Karvonen","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.npep.2012.11.001_b0090","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1210\/jc.85.4.1455","article-title":"Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with birth weight and serum triglyceride concentration in preschool aged children","volume":"85","author":"Karvonen","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.npep.2012.11.001_b0100","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0021-9150(01)00468-3","article-title":"Leucine7 to proline7 polymorphism in the preproneuropeptide Y is associated with the progression of carotid atherosclerosis, blood pressure and serum lipids in Finnish men","volume":"159","author":"Karvonen","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.npep.2012.11.001_b0105","doi-asserted-by":"crossref","first-page":"E1335","DOI":"10.1152\/ajpendo.00333.2007","article-title":"Secretion of neuropeptide Y in human adipose tissue and its role in maintenance of adipose tissue mass","volume":"293","author":"Kos","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.npep.2012.11.001_b0110","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/07853890410031236","article-title":"Neuropeptide Y and Y2-receptor are involved in development of diabetic retinopathy and retinal neovascularization","volume":"36","author":"Koulu","year":"2004","journal-title":"Ann. Med."},{"key":"10.1016\/j.npep.2012.11.001_b0115","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1161\/01.ATV.19.3.734","article-title":"The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice","volume":"19","author":"Lee","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.npep.2012.11.001_b0120","doi-asserted-by":"crossref","first-page":"12544","DOI":"10.1073\/pnas.95.21.12544","article-title":"Neuropeptides, by direct interaction with T cells, induce cytokine secretion and break the commitment to a distinct T helper phenotype","volume":"95","author":"Levite","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.npep.2012.11.001_b0125","doi-asserted-by":"crossref","first-page":"993","DOI":"10.4049\/jimmunol.160.2.993","article-title":"Neuropeptides, via specific receptors, regulate T cell adhesion to fibronectin","volume":"160","author":"Levite","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.npep.2012.11.001_b0135","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.ATV.0000071349.30914.25","article-title":"Neuropeptide Y-induced acceleration of postangioplasty occlusion of rat carotid artery","volume":"23","author":"Li","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.npep.2012.11.001_b0130","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1161\/01.ATV.0000179601.19888.19","article-title":"Chronic stress induces rapid occlusion of angioplasty-injured rat carotid artery by activating neuropeptide Y and its Y1 receptors","volume":"25","author":"Li","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.npep.2012.11.001_b0140","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.npep.2012.11.001_b0145","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.npep.2004.05.005","article-title":"NPY and Y receptors: lessons from transgenic and knockout models","volume":"38","author":"Lin","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2012.11.001_b0150","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/hq0302.104529","article-title":"Lack of plasminogen activator inhibitor-1 promotes growth and abnormal matrix remodeling of advanced atherosclerotic plaques in apolipoprotein E-deficient mice","volume":"22","author":"Luttun","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.npep.2012.11.001_b0155","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/icb.2011.6","article-title":"Y1 signalling has a critical role in allergic airway inflammation","volume":"89","author":"Macia","year":"2011","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.npep.2012.11.001_b0160","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/sj.bjp.0701154","article-title":"The neuropeptide Y (NPY) Y1 receptor antagonist BIBP 3226: equal effects on vascular responses to exogenous and endogenous NPY in the pig in vivo","volume":"121","author":"Malmstr\u00f6m","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2012.11.001_b0165","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.peptides.2011.06.007","article-title":"Neuropeptide Y modulates functions of inflammatory cells in the rat: distinct role for Y1, Y2 and Y5 receptors","volume":"32","author":"Mitic","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2012.11.001_b0170","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1096\/fj.05-4770fje","article-title":"Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors","volume":"20","author":"Movafagh","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.npep.2012.11.001_b0175","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/labinvest.2009.98","article-title":"High-fat diet induces lung remodeling in ApoE-deficient mice: an association with an increase in circulatory and lung inflammatory factors","volume":"89","author":"Naura","year":"2009","journal-title":"Lab. Invest."},{"key":"10.1016\/j.npep.2012.11.001_b0180","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0196-9781(02)00042-6","article-title":"Attenuation of hypercholesterolemia and hyperglycemia in ob\/ob mice by NPY Y2 receptor ablation","volume":"23","author":"Naveilhan","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2012.11.001_b0185","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1210\/jc.85.6.2266","article-title":"Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene is associated with enhanced carotid atherosclerosis in elderly patients with type 2 diabetes and control subjects","volume":"85","author":"Niskanen","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.npep.2012.11.001_b0190","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1152\/physrev.00005.2003","article-title":"Role of monocytes in atherogenesis","volume":"83","author":"Osterud","year":"2003","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.npep.2012.11.001_b0195","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2337\/diacare.27.2.503","article-title":"Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with proteinuria, coronary heart disease, and glycemic control in type 1 diabetic patients","volume":"27","author":"Pettersson-Fernholm","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.npep.2012.11.001_b0200","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1139\/Y08-054","article-title":"Interactions of multiple signaling pathways in neuropeptide Y-mediated bimodal vascular smooth muscle cell growth","volume":"86","author":"Pons","year":"2008","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.npep.2012.11.001_b0205","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1161\/01.CIR.0000148135.08582.97","article-title":"Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis","volume":"110","author":"Schieffer","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.npep.2012.11.001_b0210","doi-asserted-by":"crossref","first-page":"e1000318","DOI":"10.1371\/journal.pgen.1000318","article-title":"Neuropeptide Y gene polymorphisms confer risk of early-onset atherosclerosis","volume":"5","author":"Shah","year":"2009","journal-title":"PLoS Genet."},{"key":"10.1016\/j.npep.2012.11.001_b0215","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.bone.2011.10.001","article-title":"Central and peripheral mechanisms of the NPY system in the regulation of bone and adipose tissue","volume":"50","author":"Shi","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.npep.2012.11.001_b0220","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35053000","article-title":"The hormone resistin links obesity to diabetes","volume":"409","author":"Steppan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.npep.2012.11.001_b0225","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/jlb.67.4.553","article-title":"Neurotransmitters of the sympathetic nerve terminal are powerful chemoattractants for monocytes","volume":"67","author":"Straub","year":"2000","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.npep.2012.11.001_b0235","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1084\/jem.20051971","article-title":"A fundamental bimodal role for neuropeptide Y1 receptor in the immune system","volume":"202","author":"Wheway","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.npep.2012.11.001_b0230","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.2174\/156802607782341046","article-title":"NPY and receptors in immune and inflammatory diseases","volume":"7","author":"Wheway","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"issue":"Suppl.","key":"10.1016\/j.npep.2012.11.001_b0240","first-page":"229","article-title":"Atherosclerosis and angiogenesis: what do nerves have to do with it?","volume":"57","author":"Zukowska","year":"2005","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.npep.2012.11.001_b0245","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1749-6632.1995.tb44683.x","article-title":"Neuropeptide Y. A novel sympathetic stress hormone and more","volume":"771","author":"Zukowska-Grojec","year":"1995","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.npep.2012.11.001_b0250","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0167-0115(98)00073-1","article-title":"Mechanisms of vascular growth-promoting effects of neuropeptide Y: role of its inducible receptors","volume":"75\u201376","author":"Zukowska-Grojec","year":"1998","journal-title":"Regul. Pept."}],"container-title":["Neuropeptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417912001278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417912001278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T00:09:54Z","timestamp":1687910994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143417912001278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0143417912001278"],"URL":"https:\/\/doi.org\/10.1016\/j.npep.2012.11.001","relation":{},"ISSN":["0143-4179"],"issn-type":[{"value":"0143-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}